Lumos Pharma Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '25 Jun 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	-	1,216	154.55	54.21	1.17
Short-Term Investments	-	1,459	1,218	36.11	-
Cash & Short-Term Investments	2,675	2,675	1,373	90.32	1.17
Cash Growth	94.89%	94.89%	1419.81%	7619.66%	-
Accounts Receivable	-	2,140	1,548	912.81	821.66
Other Receivables	-	-	25.12	0.61	0.78
Receivables	-	2,140	1,573	913.42	822.44
Inventory	-	2,793	2,248	1,434	1,259
Prepaid Expenses	-	-	20.09	3.69	0.78
Other Current Assets	-	372.68	374.09	189.77	291.89
Total Current Assets	-	7,981	5,588	2,631	2,376
Property, Plant & Equipment	-	1,356	996.51	777.14	523
Long-Term Investments	-	-	2.14	0.4	19.81
Goodwill	-	77.4	-	-	-
Other Intangible Assets	-	10.19	9.66	6.16	3.9
Other Long-Term Assets	-	159.17	57.65	62.86	56.33
Total Assets	-	9,584	6,654	3,478	2,981
Accounts Payable	-	1,082	887.06	749.66	624.76
Accrued Expenses	-	-	11.43	6.65	8.37
Short-Term Debt	-	-	1,100	529.78	382.35
Current Portion of Long-Term Debt	-	371.45	32.53	40.54	41.26
Current Portion of Leases	-	61.19	31.11	34.27	24.12
Current Income Taxes Payable	-	27.64	17.48	15	30.97
Other Current Liabilities	-	645.54	339.88	303.04	911.24
Total Current Liabilities	-	2,187	2,419	1,679	2,023
Long-Term Debt	-	19.86	5.79	30.3	67.89
Long-Term Leases	-	225.61	124.31	184.73	182.46
Long-Term Deferred Tax Liabilities	-	13.13	6.05	5.85	3.84
Other Long-Term Liabilities	-	-	2.88	8.06	5.25
Total Liabilities	-	2,457	2,564	1,921	2,291
Common Stock	-	1,995	181.63	157.85	153
Retained Earnings	-	5,073	3,892	1,399	536.59
Total Common Equity	7,068	7,068	4,073	1,557	689.59
Minority Interest	-	59.4	16.37	-	-
Shareholders' Equity	7,127	7,127	4,090	1,557	689.59
Total Liabilities & Equity	-	9,584	6,654	3,478	2,981
Total Debt	678.12	678.12	1,293	819.62	698.08
Net Cash (Debt)	1,997	1,997	79.45	-729.3	-696.91
Net Cash Growth	2413.75%	2413.75%	-	-	-
Net Cash Per Share	10.51	10.77	0.48	-4.76	-6.14
Filing Date Shares Outstanding	198.79	198.7	181.63	157.85	153
Total Common Shares Outstanding	198.79	198.7	181.63	157.85	153
Working Capital	-	5,794	3,169	952.35	352.48
Book Value Per Share	35.57	35.57	22.43	9.87	4.51
Tangible Book Value	6,980	6,980	4,064	1,551	685.69
Tangible Book Value Per Share	35.13	35.13	22.37	9.83	4.48
Land	-	-	177.32	160.52	-
Buildings	-	-	76.59	-	-
Machinery	-	-	618.08	414.23	320.11
Construction In Progress	-	-	44.7	32.91	7
Leasehold Improvements	-	-	55.23	25.3	18.47

Updated Feb 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.